Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-30

Clinical Trial Update: Changes in Vitreous Temperature During Phacoemulsification [NA]

View source ↗

Summary

The clinical trial examining vitreous temperature changes during phacoemulsification for proliferative diabetic retinopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Proliferative Diabetic Retinopathy | NA | Status: WITHDRAWN